Ginkgo Bioworks Holdings (DNA) Notes Payables (2020 - 2021)
Ginkgo Bioworks Holdings' (DNA) quarterly Notes Payables came in at $631638.0 in Q2 2021, up 110.55% quarter-over-quarter from $300000.0 in Q4 2020.
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Notes Payables (2020 - 2021) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Notes Payables for 2 consecutive years, with $631638.0 the latest figure, recorded in Q2 2021.
- For the quarter ending Q2 2021, Notes Payables changed N/A year-over-year to $631638.0; the trailing twelve-month figure through Jun 2021 stood at $631638.0 (changed N/A YoY), and the FY2020 full-year result was $300000.0, changed N/A from the prior year.
- Notes Payables climbed to $631638.0 in Q2 2021 per DNA's latest filing, from $300000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $631638.0 in Q2 2021 and bottomed at $300000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |